| Bluffton Physician Services Llc | |
|
1026 S Main St Bluffton IN 46714-3614 | |
| (260) 919-3880 | |
| (260) 919-3882 |
| Full Name | Bluffton Physician Services Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 1026 S Main St, Bluffton, Indiana |
| Authorized Official Name and Position | Kristy Music (DIRECTOR/PROVIDER ENROLLMENT) |
| Authorized Official Contact | 6154657377 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bluffton Physician Services Llc Po Box 689022 Franklin TN 37068-9022 Ph: (615) 465-7000 | Bluffton Physician Services Llc 1026 S Main St Bluffton IN 46714-3614 Ph: (260) 919-3880 |
| NPI Number | 1003858879 |
|---|---|
| Provider Enumeration Date | 06/13/2006 |
| Last Update Date | 03/14/2024 |
| Medicare PECOS PAC ID | 7618984253 |
|---|---|
| Medicare Enrollment ID | O20060307000661 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003858879 | NPI | - | NPPES |
| 200813890 | Medicaid | IN |
| Provider Name | Robert D Bleza |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1891893731 PECOS PAC ID: 7012904915 Enrollment ID: I20040430000272 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Mary C Donley |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669467932 PECOS PAC ID: 5890722649 Enrollment ID: I20050722000587 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Mary W Saleh |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1437254950 PECOS PAC ID: 0941215164 Enrollment ID: I20060209000190 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Michael P Volpe |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1407875701 PECOS PAC ID: 2163597188 Enrollment ID: I20080826000296 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Lloyd Williams |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871565531 PECOS PAC ID: 9234102518 Enrollment ID: I20090715000550 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Marilyn V Whitney |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356317291 PECOS PAC ID: 8921109695 Enrollment ID: I20090731000075 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Harish P Ardeshna |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1386600229 PECOS PAC ID: 8123922960 Enrollment ID: I20100315000146 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Yadagiri Reddy Jonna |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083655427 PECOS PAC ID: 4688707284 Enrollment ID: I20100803000869 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Eric P Purdy |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1497799472 PECOS PAC ID: 7012811854 Enrollment ID: I20100817000474 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Carol J Butler |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1831139666 PECOS PAC ID: 9436283116 Enrollment ID: I20100817000716 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Edward Schultz |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1699719625 PECOS PAC ID: 7315927514 Enrollment ID: I20101018000055 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Pekkakuzhiyil M Mathew |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578507539 PECOS PAC ID: 6901015361 Enrollment ID: I20101109000077 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Brittany Foreman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174908164 PECOS PAC ID: 0345556205 Enrollment ID: I20150909000284 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Shelley Dunn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770969339 PECOS PAC ID: 3274840988 Enrollment ID: I20150914000377 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Stephen A Morse |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801234729 PECOS PAC ID: 0446474258 Enrollment ID: I20160803000639 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Rachel Ann Huffman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164081535 PECOS PAC ID: 9537494752 Enrollment ID: I20220906002282 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Melissa Kay Fisher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689393530 PECOS PAC ID: 2163807751 Enrollment ID: I20220919000591 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Amy M Kiel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407555188 PECOS PAC ID: 1557726148 Enrollment ID: I20230504000827 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
| Provider Name | Cheryl A. Eads |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1275679433 PECOS PAC ID: 6901103811 Enrollment ID: I20231220001660 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
According to researchers in the U.S. recurrent melanoma is more common than previously thought, and as many as 15 percent of people diagnosed with the potentially fatal skin cancer are at risk of a second diagnosis within two years.
A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique's feasibility and safety.
When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative and affect the device's function.
Now, researchers at the Garvan Institute of Medical Research, Darlinghurst in Australia, CSIRO Data61, and the School of Biotechnology and Biomolecular Sciences (UNSW) demonstrated the most comprehensive analysis of the three-dimensional structure of SARS-CoV-2, providing a new insight into how the virus infects cells and replicates.
› Verified 8 days ago
Main Street Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 117 S Main St, Bluffton, IN 46714 Phone: 260-824-9265 Fax: 260-824-9267 | |
Wells Medical Services, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 117 S Main St, Bluffton, IN 46714 Phone: 260-824-9265 Fax: 260-824-9267 | |
Meridian Health Services Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 S Main St Ste 300, Bluffton, IN 46714 Phone: 765-288-1928 | |
Markle Medical Center, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 W Horton St, Bluffton, IN 46714 Phone: 260-824-0800 Fax: 260-824-7243 | |
Meridian Health Services Corp. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1026 S Main St Ste 1, Bluffton, IN 46714 Phone: 765-228-1928 | |
George W Merkle Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 360 N Main St Ste A, Bluffton, IN 46714 Phone: 260-824-4315 Fax: 260-824-4962 |